A recent review reported that low adiponectin levels in childhood and adolescence are associated with the development of obesity-related cardiovascular complications in adulthood, and the development of metabolic syndrome, insulin resistance, and hypertension in pediatric age populations [37]. The gene discussed is ADIPOQ; the disease is metabolic syndrome.